T1	Outcomes 957 967	progressed
T2	Outcomes 980 984	died
T3	Outcomes 1017 1040	Median overall survival
T4	Outcomes 1236 1262	prostrate specific antigen
T5	Outcomes 1378 1403	Progression-free survival
T6	Outcomes 1640 1648	Toxicity
